OxFORD Asset Management LLP raised its stake in shares of Catalent Inc (NASDAQ:CTLT) by 30.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 77,427 shares of the company’s stock after purchasing an additional 18,052 shares during the quarter. OxFORD Asset Management LLP owned about 0.06% of Catalent worth $2,718,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Acrospire Investment Management LLC raised its holdings in shares of Catalent by 72.2% in the second quarter. Acrospire Investment Management LLC now owns 3,100 shares of the company’s stock worth $109,000 after buying an additional 1,300 shares during the last quarter. Quantbot Technologies LP lifted its stake in shares of Catalent by 110.7% during the second quarter. Quantbot Technologies LP now owns 3,434 shares of the company’s stock worth $120,000 after buying an additional 1,804 shares during the period. PNC Financial Services Group Inc. lifted its stake in shares of Catalent by 66.5% during the first quarter. PNC Financial Services Group Inc. now owns 6,070 shares of the company’s stock worth $173,000 after buying an additional 2,425 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of Catalent by 12.5% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 5,043 shares of the company’s stock valued at $177,000 after buying an additional 559 shares during the last quarter. Finally, Advisor Group Inc. grew its holdings in shares of Catalent by 1.3% during the second quarter. Advisor Group Inc. now owns 5,185 shares of the company’s stock valued at $180,000 after buying an additional 65 shares during the last quarter.

Several research firms recently issued reports on CTLT. ValuEngine downgraded Catalent from a “buy” rating to a “hold” rating in a research report on Monday. BidaskClub raised Catalent from a “sell” rating to a “hold” rating in a research report on Wednesday, August 16th. Needham & Company LLC initiated coverage on Catalent in a research report on Tuesday, September 12th. They set a “hold” rating and a $42.00 price target for the company. Wells Fargo & Company boosted their price target on Catalent from $39.00 to $43.00 and gave the company an “outperform” rating in a research note on Wednesday, September 20th. Finally, Bank of America Corporation reiterated a “buy” rating and set a $45.00 price target (up previously from $40.00) on shares of Catalent in a research note on Wednesday, September 20th. Six investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Catalent presently has a consensus rating of “Buy” and an average target price of $38.64.

TRADEMARK VIOLATION WARNING: This report was originally reported by Watch List News and is owned by of Watch List News. If you are accessing this report on another website, it was copied illegally and republished in violation of United States & international trademark & copyright legislation. The original version of this report can be viewed at https://www.watchlistnews.com/catalent-inc-ctlt-holdings-lifted-by-oxford-asset-management-llp/1607699.html.

Catalent Inc (NASDAQ:CTLT) opened at 41.81 on Wednesday. The stock has a market cap of $5.23 billion and a price-to-earnings ratio of 48.06. Catalent Inc has a 1-year low of $21.83 and a 1-year high of $42.22. The firm’s 50 day moving average price is $38.87 and its 200-day moving average price is $34.57.

Catalent (NASDAQ:CTLT) last released its quarterly earnings results on Monday, August 28th. The company reported $0.65 EPS for the quarter, beating the consensus estimate of $0.57 by $0.08. Catalent had a net margin of 10.02% and a return on equity of 36.29%. The firm had revenue of $616.90 million during the quarter, compared to the consensus estimate of $547.48 million. During the same quarter in the prior year, the firm earned $0.52 EPS. Catalent’s revenue for the quarter was up 15.9% on a year-over-year basis. On average, equities analysts anticipate that Catalent Inc will post $1.62 earnings per share for the current year.

In other Catalent news, SVP Christine Dolan sold 1,594 shares of the firm’s stock in a transaction on Tuesday, August 29th. The shares were sold at an average price of $38.75, for a total transaction of $61,767.50. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.

Catalent Profile

Catalent, Inc provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels.

Want to see what other hedge funds are holding CTLT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Catalent Inc (NASDAQ:CTLT).

Institutional Ownership by Quarter for Catalent (NASDAQ:CTLT)

Receive News & Ratings for Catalent Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catalent Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.